NOT FOR DISTRIBUTION
Header cover image

Market Cap

€55.7m

Last Updated

2021/04/20 19:02 UTC

Data Sources

Company Financials +

Executive Summary

Orapi SA, together with its subsidiaries, manufactures and sells professional hygiene products and industrial process products worldwide. More Details


Snowflake Analysis

Undervalued with excellent balance sheet.

Share Price & News

How has Orapi's share price performed over time and what events caused price changes?


Latest Share Price and Events

Stable Share Price: Insufficient data to determine ORAPP's volatility over the past 3 months.

Volatility Over Time: Insufficient data to determine ORAPP's volatility change over the past year.


Market Performance


7 Day Return

0%

ORAPP

-0.05%

GB Chemicals

2.1%

GB Market


1 Year Return

16.1%

ORAPP

47.9%

GB Chemicals

26.3%

GB Market

Return vs Industry: ORAPP underperformed the UK Chemicals industry which returned 53.6% over the past year.

Return vs Market: ORAPP underperformed the UK Market which returned 30.8% over the past year.


Shareholder returns

ORAPPIndustryMarket
7 Day0%-0.05%2.1%
30 Day0%4.0%3.5%
90 Dayn/a8.3%8.8%
1 Year16.1%16.1%50.2%47.9%31.9%26.3%
3 Yearn/a12.4%2.0%12.9%-0.1%
5 Yearn/a53.0%29.9%51.5%22.8%

Long-Term Price Volatility Vs. Market

How volatile is Orapi's share price compared to the market and industry in the last 5 years?


Simply Wall St News

No news available

Valuation

Is Orapi undervalued compared to its fair value and its price relative to the market?

>50%

Undervalued compared to fair value


Share Price vs. Fair Value

Below Fair Value: ORAPP (€10.45) is trading below our estimate of fair value (€386.64)

Significantly Below Fair Value: ORAPP is trading below fair value by more than 20%.


Price To Earnings Ratio

PE vs Industry: ORAPP is good value based on its PE Ratio (5.1x) compared to the GB Chemicals industry average (40.2x).

PE vs Market: ORAPP is good value based on its PE Ratio (5.1x) compared to the UK market (26.5x).


Price to Earnings Growth Ratio

PEG Ratio: ORAPP's earnings are forecast to decline next year, so we can't calculate its PEG ratio.


Price to Book Ratio

PB vs Industry: ORAPP is good value based on its PB Ratio (1x) compared to the GB Chemicals industry average (3.4x).


Future Growth

How is Orapi forecast to perform in the next 1 to 3 years based on estimates from 1 analyst?

-105.6%

Forecasted annual earnings growth


Earnings and Revenue Growth Forecasts


Analyst Future Growth Forecasts

Earnings vs Savings Rate: ORAPP's earnings are forecast to decline over the next 3 years (-105.6% per year).

Earnings vs Market: ORAPP's earnings are forecast to decline over the next 3 years (-105.6% per year).

High Growth Earnings: ORAPP's earnings are forecast to decline over the next 3 years.

Revenue vs Market: ORAPP's revenue is expected to decline over the next 3 years (-4% per year).

High Growth Revenue: ORAPP's revenue is forecast to decline over the next 3 years (-4% per year).


Earnings per Share Growth Forecasts


Future Return on Equity

Future ROE: ORAPP's Return on Equity is forecast to be low in 3 years time (2.6%).


Past Performance

How has Orapi performed over the past 5 years?

52.6%

Historical annual earnings growth


Earnings and Revenue History

Quality Earnings: ORAPP has high quality earnings.

Growing Profit Margin: ORAPP became profitable in the past.


Past Earnings Growth Analysis

Earnings Trend: ORAPP has become profitable over the past 5 years, growing earnings by 52.6% per year.

Accelerating Growth: ORAPP has become profitable in the last year, making the earnings growth rate difficult to compare to its 5-year average.

Earnings vs Industry: ORAPP has become profitable in the last year, making it difficult to compare its past year earnings growth to the Chemicals industry (-27%).


Return on Equity

High ROE: ORAPP's Return on Equity (16.2%) is considered low.


Financial Health

How is Orapi's financial position?


Financial Position Analysis

Short Term Liabilities: ORAPP's short term assets (€130.5M) exceed its short term liabilities (€90.3M).

Long Term Liabilities: ORAPP's short term assets (€130.5M) exceed its long term liabilities (€78.3M).


Debt to Equity History and Analysis

Debt Level: ORAPP's debt to equity ratio (122.8%) is considered high.

Reducing Debt: ORAPP's debt to equity ratio has reduced from 124.3% to 122.8% over the past 5 years.

Debt Coverage: ORAPP's debt is well covered by operating cash flow (40.6%).

Interest Coverage: ORAPP's interest payments on its debt are well covered by EBIT (6.4x coverage).


Balance Sheet


Dividend

What is Orapi current dividend yield, its reliability and sustainability?


Dividend Yield vs Market

Notable Dividend: Unable to evaluate ORAPP's dividend yield against the bottom 25% of dividend payers, as the company has not reported any recent payouts.

High Dividend: Unable to evaluate ORAPP's dividend yield against the top 25% of dividend payers, as the company has not reported any recent payouts.


Stability and Growth of Payments

Stable Dividend: Insufficient data to determine if ORAPP's dividends per share have been stable in the past.

Growing Dividend: Insufficient data to determine if ORAPP's dividend payments have been increasing.


Current Payout to Shareholders

Dividend Coverage: ORAPP is not paying a notable dividend for the UK market.


Future Payout to Shareholders

Future Dividend Coverage: No need to calculate the sustainability of ORAPP's dividend in 3 years as they are not forecast to pay a notable one for the UK market.


Next Steps

Management

How experienced are the management team and are they aligned to shareholders interests?

9.5yrs

Average board tenure


CEO

Guy Chifflot

no data

Tenure

€537,000

Compensation

Mr. Monsieur Guy Chifflot serves as the Chairman, Chief Executive Officer and President of Orapi. Mr. Chifflot serves as a Manager of ORAPI Europe and Orapi International. Mr. Chifflot serves as the Managi...


CEO Compensation Analysis

Compensation vs Market: Guy's total compensation ($USD645.98K) is above average for companies of similar size in the UK market ($USD335.73K).

Compensation vs Earnings: Guy's compensation has been consistent with company performance over the past year.


Board Members

Experienced Board: ORAPP's board of directors are considered experienced (9.5 years average tenure).


Ownership

Who are the major shareholders and have insiders been buying or selling?


Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.


Ownership Breakdown

Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 43.5%.


Top Shareholders

Company Information

Orapi SA's company bio, employee growth, exchange listings and data sources


Key Information

  • Name: Orapi SA
  • Ticker: ORAPP
  • Exchange: BATS-CHIXE
  • Founded: 1968
  • Industry: Specialty Chemicals
  • Sector: Materials
  • Market Cap: €55.747m
  • Shares outstanding: 6.57m
  • Website: https://www.orapi.com

Number of Employees


Location

  • Orapi SA
  • Parc industriel de la plaine de l'ain
  • 225 AllEe des cEdres
  • Saint-Vulbas
  • Rhône-Alpes
  • 1150
  • France

Listings


Biography

Orapi SA, together with its subsidiaries, manufactures and sells professional hygiene products and industrial process products worldwide. The company provides cleaning and disinfection products, and produc...


Company Analysis and Financial Data Status

All financial data provided by Standard & Poor's Capital IQ.
DataLast Updated (UTC time)
Company Analysis2021/04/20 19:02
End of Day Share Price2021/01/21 00:00
Earnings2020/12/31
Annual Earnings2020/12/31


Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.